Introduction
Dural arteriovenous fistulae (DAVF) are acquired, direct connections between an artery and a vein without an intervening capillary network. Resultant venous hypertension may cause tissue oedema, hypoxia and ultimately, infarction. Spinal DAVF connect a radiculomedullary artery and vein, causing spinal cord oedema that classically manifests with an insidiously progressive or fluctuating myelopathy. Identification of dilated perimedullary veins through careful inspection of MR images is usually pivotal in making the diagnosis. Embolization or surgical disconnection can stabilize or improve neurological disability. However, late diagnosis is common, resulting in significant disability in many cases [
1].
The vast majority of spinal DAVF are thoracolumbar; only 2% are cervical [
2]. However, intracranial DAVF can also drain into spinal perimedullary veins as they enter the skull, causing brainstem or cervical cord oedema (Cognard type V DAVF) [
3]. Such cases are considered rare, but are probably under-diagnosed and often mistaken for acute transverse myelitis (ATM), a far commoner cause of cervical myelopathy [
4,
5]. Misdiagnosis may have grave consequences, because steroids, the standard treatment for ATM, can prompt rapid neurological deterioration in half of spinal DAVF cases [
6]. Ascending cervical cord oedema could lead to ventilatory failure.
In this study, we identified all Cognard type V DAVF diagnosed at a tertiary UK neuroscience centre, which serves 3.5 million people. The objective was to review the diagnostic characteristics of these cases, identifying pitfalls and clues that may aid earlier differentiation from ATM.
Discussion
Over a 5.5-year period, only six Cognard type V DAVF were identified, but this equated to 1 for every 4.5 cases of ‘typical’ spinal DAVF. Inevitably, due to the difficulty of diagnosing DAVF, an unknown number of cases could remain undetected, even retrospectively. Frequent misdiagnosis (83%) and potentially life-threatening consequences of steroid administration were observed. Only patients with cervical cord swelling received steroids. This is presumably because it is usually lower thoracic cord swelling that leads neurologists to consider the possibility of DAVF. Cervical myelopathies are most often inflammatory, including multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD). Clinicians were probably also misled here by ‘inflammatory’ CSF abnormalities and imaging pitfalls, including intramedullary gadolinium enhancement and the absence of dilated perimedullary veins.
Demographic characteristics appeared important clues to an underlying DAVF. Our series aligns with the previously reported preponderance for spinal DAVF to affect older males. Five males for every one female are diagnosed with spinal DAVF and only 1% present before age 30 years [
2]. Conversely ATM occurs frequently in young patients, and aquaporin-4 antibody-mediated NMOSD, the archetypal cause of longitudinally extensive ATM, preferentially affects females (sex ratio 3:1–9:1) [
7]. Thus, DAVF should be strongly considered in all older male patients with longitudinally extensive cord swelling, both cervical and thoracolumbar.
Temporal progression is also important to consider. At presentation, all cases had been symptomatic for over 4 weeks, whereas ATM reaches a nadir within 3 weeks [
8]. Four patients experienced an acute on chronic deterioration, which mimicked ATM, but this is recognised to occur with DAVF, particularly with surges in venous pressure (exercise or Valsalva manoeuvre). In a series of spinal DAVF, 63% progressed gradually, 26% had episodes of acute deterioration superimposed on a gradually progressive course, and 5% experienced an acute onset [
9]. Progression of symptoms beyond 4 weeks should, therefore, be considered a red flag suggestive of a non-ATM diagnosis, and acute deterioration should not stop clinicians looking for a DAVF.
Importantly, steroids can cause dramatic clinical deterioration of DAVF, probably through transient mineralocorticoid-induced hypervolemia and venous hypertension [
4‐
6,
10]. This can be life-threatening with high cervical cord involvement, as observed in our case of sudden respiratory failure. A case of transient clinical improvement was also identified. This phenomenon has been reported previously and may reflect reduction of cord oedema [
11,
12].
CSF findings in DAVF are poorly studied, but albuminocytological dissociation was reported as early as 1926 by Charles Foix and Théophile Alajouanine (likely the earliest description of spinal DAVF) [
13] and in contemporary angiographically confirmed cases [
10]. In this series, 80% demonstrated albuminocytological dissociation. Elevated CSF protein is a non-specific finding that does not always indicate inflammatory or infective pathology. Mild elevation may be seen purely as an age-related phenomenon in those over 50 years, and vascular disorders, including DAVF, can cause CSF protein elevation through blood-CSF barrier disruption. In the context of longitudinally extensive cord swelling, the CSF white cell count is more reliable marker of inflammation. Acellular CSF is unusual in the context of longitudinally extensive ATM and is, therefore, an important red flag to look for a vascular aetiology.
The diagnosis of DAVF usually rests on standard MRI, can be guided by MR angiography (MRA) and is confirmed by digital subtraction angiography (DSA). In T2-weighted MRI, DAVF-related cord oedema is hyperintense, longitudinally extensive, centromedullary and poorly delineated [
14]. Cognard type V DAVF have been reported to cause a characteristic pattern of central brainstem oedema with sparing of the periphery as well as internal linear segments in a tigroid pattern [
15]. Asymmetric brainstem involvement, as seen in case 2, has also been reported [
12].
Cord surface flow voids, caused by dilated perimedullary veins, strongly suggest a DAVF and must be carefully looked for. Specialist neuroradiologist review improved detection in our series, but flow voids were nevertheless identified in only 33%. They may be absent if the shunt volume is small, and conversely, pulsation artefact or venous obstruction by gross cord swelling may mimic DAVF [
14]. A review of published Cognard type V DAVF cases reported a 37% sensitivity of T2-weighted MRI for spinal vein enlargement [
16], which is similar to its sensitivity for spinal DAVF [
17]. Gadolinium improves sensitivity for enlarged perimedullary veins, as seen in case 2. In one study, careful examination of Gadolinium-enhanced T1-weighted images improved detection of dilated perimedullary vessels from 37 to 76%, demonstrating a clear benefit of contrast administration for Cognard type V DAVF diagnosis [
12].
Intramedullary gadolinium enhancement was observed in 33% of our cases, which is frequently considered indicative of inflammatory, infectious or neoplastic lesions. However, pathological enhancement is reported in half of spinal DAVF cases, due to blood-spinal cord barrier disruption [
14,
17]. A non-enhancing cord segment amidst the enhancement (‘the missing piece sign’) due to inconsistent venous drainage, may be particularly suggestive of spinal DAVF over ATM [
18]. Cognard type V DAVF have been reported to cause intense central or patchy brainstem enhancement, which may be mistaken for brainstem glioma [
12,
15].
First-pass gadolinium-enhanced MRA can further aid diagnosis, by demonstrating early venous filling and helping to localise the shunt, which may be remote from the cord oedema [
14]. This can avoid injections of all possible arterial feeders during DSA, which remains the gold standard diagnostic test for DAVF. Critically, investigation of suggestive cervical cord lesions must include cranial angiography, including selective injection of the external carotid arteries.
All patients in this series improved following obliteration of their DAVF but had residual disability. As a treatable condition, early diagnosis minimises long-term sequelae. Unfortunately, diagnostic delays are common, even with typical thoracolumbar DAVF. In one series, median diagnostic delay was 6 months, during which 96% of patients deteriorated [
1]. The stakes are even higher with cervical cord involvement, underscoring the importance of considering DAVF in this context.